IPSC
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
75.76M
49 days until earnings call
NKTR
Price
$0.92
Change
+$0.02 (+2.22%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
169.33M
35 days until earnings call
Ad is loading...

IPSC vs NKTR

Header iconIPSC vs NKTR Comparison
Open Charts IPSC vs NKTRBanner chart's image
Century Therapeutics
Price$0.90
Change-$0.00 (-0.00%)
Volume$2.96K
Capitalization75.76M
Nektar Therapeutics
Price$0.92
Change+$0.02 (+2.22%)
Volume$11.97K
Capitalization169.33M
IPSC vs NKTR Comparison Chart
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. NKTR commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a StrongBuy and NKTR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (IPSC: $0.89 vs. NKTR: $0.92)
Brand notoriety: IPSC: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 45% vs. NKTR: 42%
Market capitalization -- IPSC: $75.76M vs. NKTR: $169.33M
IPSC [@Biotechnology] is valued at $75.76M. NKTR’s [@Biotechnology] market capitalization is $169.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, NKTR is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 5 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • IPSC’s TA Score: 5 bullish, 2 bearish.
  • NKTR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than NKTR.

Price Growth

IPSC (@Biotechnology) experienced а -5.42% price change this week, while NKTR (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

IPSC is expected to report earnings on May 08, 2025.

NKTR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($169M) has a higher market cap than IPSC($75.8M). NKTR YTD gains are higher at: -1.290 vs. IPSC (-11.782). IPSC has higher annual earnings (EBITDA): -117.21M vs. NKTR (-137.77M). NKTR has more cash in the bank: 244M vs. IPSC (198M). IPSC has less debt than NKTR: IPSC (54.6M) vs NKTR (108M). NKTR has higher revenues than IPSC: NKTR (93.1M) vs IPSC (2.68M).
IPSCNKTRIPSC / NKTR
Capitalization75.8M169M45%
EBITDA-117.21M-137.77M85%
Gain YTD-11.782-1.290913%
P/E RatioN/AN/A-
Revenue2.68M93.1M3%
Total Cash198M244M81%
Total Debt54.6M108M51%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCNKTR
RSI
ODDS (%)
Bullish Trend 16 days ago
84%
Bearish Trend 16 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 16 days ago
68%
Bearish Trend 16 days ago
90%
Momentum
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 16 days ago
79%
MACD
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 16 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 16 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
74%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
Aroon
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
86%
View a ticker or compare two or three
Ad is loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAIA5.450.32
+6.24%
Gaia
YRD5.15N/A
N/A
Yiren Digital Ltd
CODI21.36-0.01
-0.05%
Compass Diversified
ALTR110.40-0.22
-0.20%
Altair Engineering
MS136.00-1.30
-0.95%
Morgan Stanley

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with NKTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-0.69%
NKTX - IPSC
48%
Loosely correlated
+1.64%
ARVN - IPSC
47%
Loosely correlated
-1.88%
ABCL - IPSC
45%
Loosely correlated
+15.36%
MGTX - IPSC
45%
Loosely correlated
-5.77%
FATE - IPSC
44%
Loosely correlated
+1.52%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with NTLA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+1.55%
NTLA - NKTR
42%
Loosely correlated
+10.76%
SLS - NKTR
42%
Loosely correlated
-0.87%
DNLI - NKTR
41%
Loosely correlated
+1.17%
IPSC - NKTR
38%
Loosely correlated
-0.69%
MDGL - NKTR
38%
Loosely correlated
+5.74%
More